unnamed (1)

March 18, 2025

Bausch + Lomb Launches Arise Orthokeratology Lens System in the United States

Bausch + Lomb has branded Arise as a faster, smarter and seamless ortho-k lens fitting system. On March 17, 2025,…

Thumbnail_article___1200x675_Sydnexis_FDA_NDA_Acceptance_and_PDUFA_date

March 12, 2025

Sydnexis Receives FDA Acceptance for SYD-101 New Drug Application for Pediatric Myopia

The low-dose atropine formulation could be the first approved drug in the United States to slow myopia in children. On…

popular posts

Thumbnail article and Quote

September 1, 2023

Three-Year Study Reports Low-Dose Atropine is Less Effective Than Placebo

latest posts

Thumbnail Eyerising 01

April 15, 2024

Prof. Mingguang He on RLRL: Myopia Control Breakthrough or Bust?

CHIC 01

January 29, 2024

From Geek to Chic: A Jordanian study highlights changing trends in eyeglasses perception

shutterstock_1904344684

January 5, 2024

Specs and Control: Embracing the promise of myopia control-specific spectacles

Seeing Eye to Eye: The door is open for ODs and MDs to work together on a new myopia co management paradigm

January 4, 2024

Seeing Eye to Eye: The door is open for ODs and MDs to work together on a new myopia co-management paradigm

shutterstock_563126542

January 8, 2024

The Promise of Ortho-K: An alternative to laser eye surgery, orthokeratology proves effective at correcting myopia

shutterstock_1914113845

November 8, 2023

A Look at Atropine: Three-year study reports atropine is less effective than placebo in myopia control

Group 1

November 7, 2023

Championing Myopia Control: WCO’s Dr. Sandra Block addresses today’s growing need to elevate the standard of care in myopia management

shutterstock_638016085 [Converted] 01

December 18, 2023

The Lens Luminary: In the realm of specialty contact lenses and myopia control, Dr. Ashley Tucker fights vision loss one lens at a time

Discover our fascinating content at issuu

explore